Literature DB >> 8506286

Extrathymic differentiation of T lymphocytes and natural killer cells from human embryonic liver precursors.

A Poggi1, M Sargiacomo, R Biassoni, N Pella, S Sivori, V Revello, P Costa, M Valtieri, G Russo, M C Mingari.   

Abstract

Liver cells were isolated on Ficoll/Hypaque gradients from embryos or fetuses at 6-10 weeks of gestation; 2-20% of the cells expressed CD45 or HLA class I surface antigens and 2-6% expressed CD7. Other T- or natural-killer (NK)-cell-lineage-specific markers were undetectable. Liver-cell suspensions cultured in the presence of phytohemagglutinin and recombinant interleukin 2 gave rise to large proportions of CD3+ lymphocytes expressing either alpha/beta or gamma/delta T-cell receptors. This occurred not only in bulk cultures but also when cells were cloned under limiting dilution conditions. Importantly, these figures were obtained also in embryos at 6-8 weeks of gestation, which is before colonization of the thymic rudiment by T-cell precursors. When the same liver-cell suspensions were cultured in the presence of irradiated H9 cells and recombinant interleukin 2 (either in bulk cultures or under cloning conditions), large proportions of cells (or clones) expressed surface CD16 and CD56 antigens and displayed a strong cytolytic activity against both NK-sensitive (K562) and NK-resistant (M14) target cells. In addition, liver-derived T or NK cells expressed functional receptor molecules since they could be activated via either CD3/T-cell receptor or CD16 surface antigens, respectively. Further fractionation of liver cells on the basis of CD45 antigen expression indicated that only CD45+ cells could give rise to T or NK cells in culture. Thus, CD45 can be used as a marker for identification of an early liver-cell population containing T- and NK-cell precursors. That T or NK cells were derived from male embryos and not from the mother was shown by PCR amplification of X and Y chromosomal sequences. Our present data may offer an in vitro model for extrathymic embryonic T-cell maturation that can be used to examine fundamental aspects of human T-cell development and function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8506286      PMCID: PMC46532          DOI: 10.1073/pnas.90.10.4465

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  A T-cell receptor gamma/CD3 complex found on cloned functional lymphocytes.

Authors:  J Borst; R J van de Griend; J W van Oostveen; S L Ang; C J Melief; J G Seidman; R L Bolhuis
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

2.  Haemoglobin switching in human embryos: asynchrony of zeta----alpha and epsilon----gamma-globin switches in primitive and definite erythropoietic lineage.

Authors:  C Peschle; F Mavilio; A Carè; G Migliaccio; A R Migliaccio; G Salvo; P Samoggia; S Petti; R Guerriero; M Marinucci
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

3.  The embryonic thymus produces chemotactic peptides involved in the homing of hemopoietic precursors.

Authors:  S Champion; B A Imhof; P Savagner; J P Thiery
Journal:  Cell       Date:  1986-03-14       Impact factor: 41.582

4.  Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): analysis of the functional relationship among different pathways of activation.

Authors:  A Moretta; A Poggi; D Olive; C Bottino; C Fortis; G Pantaleo; L Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

Review 5.  Ontogeny of primary lymphoid organs and lymphoid stem cells.

Authors:  N M Le Douarin; F Dieterlen-Lièvre; P D Oliver
Journal:  Am J Anat       Date:  1984-07

6.  Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.

Authors:  A Moretta; G Pantaleo; L Moretta; J C Cerottini; M C Mingari
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

7.  Development of lymphocyte subpopulations identified by monoclonal antibodies in human fetuses.

Authors:  W A Kamps; M D Cooper
Journal:  J Clin Immunol       Date:  1984-01       Impact factor: 8.317

8.  Human T cell antigen expression during the early stages of fetal thymic maturation.

Authors:  D F Lobach; L L Hensley; W Ho; B F Haynes
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

9.  Human embryonic hemopoiesis. Kinetics of progenitors and precursors underlying the yolk sac----liver transition.

Authors:  G Migliaccio; A R Migliaccio; S Petti; F Mavilio; G Russo; D Lazzaro; U Testa; M Marinucci; C Peschle
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

10.  Putative prethymic T cell precursors within the early human embryonic liver: a molecular and functional analysis.

Authors:  M J Sánchez; J C Gutiérrez-Ramos; E Fernández; E Leonardo; J Lozano; C Martínez; M L Toribio
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

View more
  4 in total

1.  Immunomodulation by vitamin B12: augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment.

Authors:  J Tamura; K Kubota; H Murakami; M Sawamura; T Matsushima; T Tamura; T Saitoh; H Kurabayshi; T Naruse
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 2.  Biology and clinical impact of human natural killer cells.

Authors:  Sherif S Farag; Jeffrey B VanDeusen; Todd A Fehniger; Michael A Caligiuri
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

Review 3.  Human NK cells: surface receptors, inhibitory checkpoints, and translational applications.

Authors:  Simona Sivori; Paola Vacca; Genny Del Zotto; Enrico Munari; Maria Cristina Mingari; Lorenzo Moretta
Journal:  Cell Mol Immunol       Date:  2019-02-18       Impact factor: 11.530

Review 4.  Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation.

Authors:  Daniela Pende; Michela Falco; Massimo Vitale; Claudia Cantoni; Chiara Vitale; Enrico Munari; Alice Bertaina; Francesca Moretta; Genny Del Zotto; Gabriella Pietra; Maria Cristina Mingari; Franco Locatelli; Lorenzo Moretta
Journal:  Front Immunol       Date:  2019-05-28       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.